Pseudomonas aeruginosa pyocyanin inactivates lung epithelial vacuolar ATPase-dependent cystic fibrosis transmembrane conductance regulator expression and localization
- PMID: 16819965
- DOI: 10.1111/j.1462-5822.2006.00696.x
Pseudomonas aeruginosa pyocyanin inactivates lung epithelial vacuolar ATPase-dependent cystic fibrosis transmembrane conductance regulator expression and localization
Abstract
Pseudomonas aeruginosa (PA) is a major pathogen causing morbidity and ultimately mortality in patients afflicted with cystic fibrosis (CF) lung disease. One important virulence factor, pyocyanin (PCN), is a blue, redox-active compound that is secreted in such copious amounts by PA in the CF lungs that it determines the colour of expectorated sputum. In this study, we discovered that physiological concentrations of PCN inactivate the airway epithelial vacuolar ATPase, resulting in reduced expression and trafficking of the cystic fibrosis transmembrane conductance regulator in cultured lung and primary nasal epithelial cells. Our study supports the notion that PCN contributes significantly to the pathogenesis of CF and other bronchiectasis patients infected by PA.
Similar articles
-
Role of the cystic fibrosis transmembrane conductance regulator in internalization of Pseudomonas aeruginosa by polarized respiratory epithelial cells.Cell Microbiol. 2004 Jun;6(6):521-33. doi: 10.1111/j.1462-5822.2004.00380.x. Cell Microbiol. 2004. PMID: 15104594
-
Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice.Infect Immun. 2004 Jul;72(7):4275-8. doi: 10.1128/IAI.72.7.4275-4278.2004. Infect Immun. 2004. PMID: 15213173 Free PMC article.
-
Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells: analysis of the effects of cystic fibrosis transmembrane conductance regulator dysfunction and bacterial virulence factors.Am J Respir Cell Mol Biol. 2000 Sep;23(3):304-12. doi: 10.1165/ajrcmb.23.3.4098. Am J Respir Cell Mol Biol. 2000. PMID: 10970820
-
The role of pyocyanin in Pseudomonas aeruginosa infection.Trends Mol Med. 2004 Dec;10(12):599-606. doi: 10.1016/j.molmed.2004.10.002. Trends Mol Med. 2004. PMID: 15567330 Review.
-
Rationale for hypertonic saline therapy for cystic fibrosis lung disease.Semin Respir Crit Care Med. 2007 Jun;28(3):295-302. doi: 10.1055/s-2007-981650. Semin Respir Crit Care Med. 2007. PMID: 17562499 Review.
Cited by
-
Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.Clin Infect Dis. 2015 Mar 1;60(5):703-12. doi: 10.1093/cid/ciu944. Epub 2014 Nov 25. Clin Infect Dis. 2015. PMID: 25425629 Free PMC article.
-
Inflammation as a Regulator of the Airway Surface Liquid pH in Cystic Fibrosis.Cells. 2023 Apr 7;12(8):1104. doi: 10.3390/cells12081104. Cells. 2023. PMID: 37190013 Free PMC article. Review.
-
Effects of indacaterol on the LPS-evoked changes in fluid secretion rate and pH in swine tracheal membrane.Pflugers Arch. 2021 Jun;473(6):883-896. doi: 10.1007/s00424-021-02560-z. Epub 2021 May 24. Pflugers Arch. 2021. PMID: 34031755 Free PMC article.
-
Pyocyanin effects on respiratory epithelium: relevance in Pseudomonas aeruginosa airway infections.Trends Microbiol. 2013 Feb;21(2):73-81. doi: 10.1016/j.tim.2012.10.004. Epub 2012 Nov 7. Trends Microbiol. 2013. PMID: 23140890 Free PMC article. Review.
-
Tobramycin reduces key virulence determinants in the proteome of Pseudomonas aeruginosa outer membrane vesicles.PLoS One. 2019 Jan 25;14(1):e0211290. doi: 10.1371/journal.pone.0211290. eCollection 2019. PLoS One. 2019. PMID: 30682135 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical